(Circulation. 2000;102:3009.)
© 2000 American Heart Association, Inc.
Basic Science Reports |
From the Laboratory of Cardiovascular Science, Intramural Research Program, National Institute on Aging, Baltimore, Md.
Correspondence to Alexei Y. Bagrov, Laboratory of Cardiovascular Science, National Institute on Aging, 5600 Nathan Shock Dr, Baltimore, MD 21224.
BackgroundTwo mammalian
digitalis-like factors, an ouabain-like compound (OLC) and
marinobufagenin (MBG), exhibit specificity to
-3 and
-1
Na+,K+-ATPase isoforms, respectively. We
compared regulation of MBG and OLC by acute NaCl loading in Dahl
salt-sensitive (DS) and salt-resistant (DR) rats.
Methods and ResultsAn intraperitoneal NaCl
load (0.8 g/kg) was given to adult male rats (24 DS and 24 DR).
Diuresis, natriuresis, renal excretion, and tissue levels of
MBG and OLC were measured. Inhibition of renal
Na+,K+-ATPase by MBG and ouabain was compared
in DS, DR, and Wistar rats. DS (versus DR) exhibited a smaller peak (2
hours) natriuretic response (1.34±0.10 versus
2.08±0.14 mmol · kg-1 ·
h-1; P<0.01), despite a
greater plasma Na+ (153±2 versus 145±1 mmol/L;
P<0.01). In DS and DR, pituitary, adrenal, and plasma
OLC exhibited transient 2-fold to 3-fold increases, followed by a
decrease to baseline levels. Plasma and adrenal MBG doubled in both
strains within 1 hour of NaCl loading and remained elevated. Eight-hour
MBG excretion in DS was 4-fold greater than in DR (15.8±0.8 versus
3.6±0.4 pmol; P<0.01), whereas OLC excretion in DS was
only 30% greater than in DR (16.1±1.1 and 11.9±0.8 pmol;
P<0.05). Kidney Na+,K+-ATPase
(
-1 isoform) from Wistar rats and DS exhibited greater sensitivity
to MBG than to ouabain.
ConclusionsNaCl loading of DS causes transient increase in OLC but sustained increases in MBG tissue levels and excretion. We hypothesize that increased MBG production occurs in an attempt to compensate for genetically impaired pressure-natriuresis mechanisms.
Key Words: hypertension rats, inbred Dahl sodium, dietary Na(+)-K(+)-exchanging ATPase steroids bufanolides ouabain
This article has been cited by other articles:
![]() |
W. Schoner and G. Scheiner-Bobis Role of endogenous cardiotonic steroids in sodium homeostasis Nephrol. Dial. Transplant., June 13, 2008; (2008) gfn325v1. [Full Text] [PDF] |
||||
![]() |
D. E. Anderson, O. V. Fedorova, C. H. Morrell, D. L. Longo, V. A. Kashkin, J. D. Metzler, A. Y. Bagrov, and E. G. Lakatta Endogenous sodium pump inhibitors and age-associated increases in salt sensitivity of blood pressure in normotensives Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1248 - R1254. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Schoner and G. Scheiner-Bobis Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth Am J Physiol Cell Physiol, August 1, 2007; 293(2): C509 - C536. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Onozato, A. Tojo, N. Kobayashi, A. Goto, H. Matsuoka, and T. Fujita Dual blockade of aldosterone and angiotensin II additively suppresses TGF-{beta} and NADPH oxidase in the hypertensive kidney Nephrol. Dial. Transplant., May 1, 2007; 22(5): 1314 - 1322. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yoshika, Y. Komiyama, M. Konishi, T. Akizawa, T. Kobayashi, M. Date, S. Kobatake, M. Masuda, H. Masaki, and H. Takahashi Novel Digitalis-Like Factor, Marinobufotoxin, Isolated From Cultured Y-1 Cells, and Its Hypertensive Effect in Rats Hypertension, January 1, 2007; 49(1): 209 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. V. Fedorova, N. I. Agalakova, C. H. Morrell, E. G. Lakatta, and A. Y. Bagrov ANP Differentially Modulates Marinobufagenin-Induced Sodium Pump Inhibition in Kidney and Aorta Hypertension, December 1, 2006; 48(6): 1160 - 1168. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kennedy, S Vetteth, S. Periyasamy, M Kanj, L Fedorova, S Khouri, M. Kahaleh, Z Xie, D Malhotra, N. Kolodkin, et al. Uremic Cardiomyopathy--An Endogenous Digitalis Intoxication?: Central Role for the Cardiotonic Steroid Marinobufagenin in the Pathogenesis of Experimental Uremic Cardiomyopathy. Hypertension 47: 488-495, 2006 J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1493 - 1497. [Full Text] [PDF] |
||||
![]() |
T. Iwamoto Vascular Na+/Ca2+ exchanger: implications for the pathogenesis and therapy of salt-dependent hypertension Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R536 - R545. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Wasserstrom and G. L. Aistrup Digitalis: new actions for an old drug Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H1781 - H1793. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Abramowitz, C. Dai, K. K. Hirschi, R. I. Dmitrieva, P. A. Doris, L. Liu, and J. C. Allen Ouabain- and Marinobufagenin-Induced Proliferation of Human Umbilical Vein Smooth Muscle Cells and a Rat Vascular Smooth Muscle Cell Line, A7r5 Circulation, December 16, 2003; 108(24): 3048 - 3053. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Thongboonkerd, J. B. Klein, W. M. Pierce, A. W. Jevans, and J. M. Arthur Sodium loading changes urinary protein excretion: a proteomic analysis Am J Physiol Renal Physiol, June 1, 2003; 284(6): F1155 - F1163. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. V. Fedorova, M. I. Talan, N. I. Agalakova, M.-T. Droy-Lefaix, E. G. Lakatta, and A. Y. Bagrov Myocardial PKC {beta}2 and the Sensitivity of Na/K-ATPase to Marinobufagenin Are Reduced by Cicletanine in Dahl Hypertension Hypertension, March 1, 2003; 41(3): 505 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. I. Dmitrieva and P. A. Doris Cardiotonic Steroids: Potential Endogenous Sodium Pump Ligands with Diverse Function Experimental Biology and Medicine, September 1, 2002; 227(8): 561 - 569. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wang and F. H.H. Leenen Brain Sodium Channels Mediate Increases in Brain "Ouabain" and Blood Pressure in Dahl S Rats Hypertension, July 1, 2002; 40(1): 96 - 100. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. V. Fedorova, N. A. Dorofeeva, D. A. Lopatin, E. G. Lakatta, and A. Y. Bagrov Phorbol Diacetate Potentiates Na+-K+ ATPase Inhibition by a Putative Endogenous Ligand, Marinobufagenin Hypertension, February 1, 2002; 39(2): 298 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. V. Fedorova, N. I. Kolodkin, N. I. Agalakova, E. G. Lakatta, and A. Y. Bagrov Marinobufagenin, an Endogenous {{alpha}}-1 Sodium Pump Ligand, in Hypertensive Dahl Salt-Sensitive Rats Hypertension, February 1, 2001; 37(2): 462 - 466. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. V. Fedorova, M. I. Talan, N. I. Agalakova, E. G. Lakatta, and A. Y. Bagrov Endogenous Ligand of {alpha}1 Sodium Pump, Marinobufagenin, Is a Novel Mediator of Sodium Chloride-Dependent Hypertension Circulation, March 5, 2002; 105(9): 1122 - 1127. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |